Cathelicidin and Vitamin D: Impact on Populations At-Risk and With COPD

NCT02464059 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Vitamin D3

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]